Sou Hu Cai Jing·2025-11-22 22:12Core Points - As of November 21, 2025, BeiGene (688235) closed at 278.88 CNY, down 6.67% from 298.8 CNY the previous week, with a market cap of 429.664 billion CNY, ranking 1st in the chemical pharmaceutical sector and 30th among all A-shares [1][4] Company Announcements - On November 10, 2025, BeiGene's board granted a total of 16,463 restricted stock units to 143 recipients under the 2016 option and incentive plan, involving 214,019 shares, approximately 0.01% of the total issued shares, with a zero grant price and no performance targets or clawback mechanisms [1][4] - On November 13, 2025, BeiGene signed a credit agreement with HSBC and other financial institutions, securing up to 700 million USD in senior secured credit, including approximately 300 million CNY in term loans for general corporate purposes and refinancing, along with 140 million USD in revolving loans and 560 million USD in term loans for similar purposes [1][4]